Hydroxyzinum Polfarmex

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzinum Polfarmex, is a first‑generation antihistamine presented as an oral dosage form for oral use. It is employed to relieve allergic skin reactions, manage anxiety and tension, provide sedation before or after surgical procedures, and control nausea and vomiting in appropriate patients.

GNH USA supplies Hydroxyzinum Polfarmex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable global logistics through established distribution networks.

Hydroxyzine Hydrochloride is used to treat conditions mediated by histamine release and central nervous system excitation. - Allergic dermatoses and pruritus: reduces itching and skin inflammation associated with allergic reactions. - Anxiety and tension relief: provides a calming effect and reduces subjective anxiety in patients. - Sedation for surgical procedures: induces pre‑operative or post‑operative sedation and anxiolysis. - Nausea and vomiting: helps control nausea and vomiting related to various causes.

Hydroxyzine Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation causing a dry sensation. - Dizziness: light‑headed feeling, especially on standing. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm that may require medical attention. - Severe allergic reaction: rash, swelling, or breathing difficulty indicating possible anaphylaxis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Seizures: convulsive episodes in susceptible individuals.

When prescribing Hydroxyzine Hydrochloride, clinicians should consider several precautionary measures to ensure safe use. - Assess renal and hepatic function: adjust use in patients with significant impairment. - Avoid concomitant CNS depressants: increased sedation risk when combined with alcohol or opioids. - Monitor elderly patients: higher susceptibility to drowsiness, falls and anticholinergic effects. - Caution in pregnancy: limited data; use only if potential benefit outweighs risk. - Contraindicated in hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Hydroxyzine Hydrochloride can interact with other medicines, altering its effects or increasing adverse reactions.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and sedation. - CNS depressants (benzodiazepines, opioids): additive sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: enhanced anticholinergic burden leading to dry mouth, constipation, urinary retention. - QT‑prolonging drugs (e.g., quinidine, erythromycin): may increase risk of cardiac arrhythmias. - Alcohol: potentiates drowsiness and impairment.